Cutting NIH funding puts my life on the line — and maybe yours as well
Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...
Helix Launches World's Largest Clinico-Genomic Cohort of GLP-1 Agonist Treated Patients
Helix, a leader in precision health, is unveiling a new comprehensive clinico-genomic dataset of over 15,000 patients treated with glucagon-like-peptide-1 (GLP-1) agonists including semaglutide, ...
Fin vs Fin on MSN11d
Found vs Calibrate: Which Is Better For Prescription Weight Loss?
Fitness and nutrition gurus like to make weight loss sound easy. But in reality, it’s often incredibly tough to incorporate ...
How GLP-1 medications are transforming diabetes and weight loss treatment
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
Ozempic, Wegovy may help mental health, substance disorders
An observational analysis has found that the drugs may lower the risk of substance abuse and cognitive issues. But the findings need clinical testing.